We are upgrading the repository! The content freeze has been extended to December 11, 2024, when we expect the new repository to become available. New submissions or changes to existing items will not be allowed until after the new website goes live. All content already published will remain publicly available for searching and downloading. Updates will be posted in the Website Upgrade 2024 FAQ in the sidebar Help menu. Reach out to escholarship@umassmed.edu with any questions.
Inherited DOCK2 Deficiency in Patients with Early-Onset Invasive Infections
UMass Chan Affiliations
Department of Pediatrics, Division of GeneticsDocument Type
Journal ArticlePublication Date
2015-06-18Keywords
B-LymphocytesChild, Preschool
Fatal Outcome
Female
Genes, Recessive
Genetic Diseases, Inborn
Guanine Nucleotide Exchange Factors
Hematopoietic Stem Cell Transplantation
Humans
Immunologic Deficiency Syndromes
Infant
Killer Cells, Natural
Male
*Mutation
Pedigree
T-Lymphocytes
rac1 GTP-Binding Protein
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Genetics
Immune System Diseases
Immunity
Immunology of Infectious Disease
Medical Genetics
Molecular Genetics
Metadata
Show full item recordAbstract
Background Combined immunodeficiencies are marked by inborn errors of T-cell immunity in which the T cells that are present are quantitatively or functionally deficient. Impaired humoral immunity is also common. Patients have severe infections, autoimmunity, or both. The specific molecular, cellular, and clinical features of many types of combined immunodeficiencies remain unknown. Methods We performed genetic and cellular immunologic studies involving five unrelated children with early-onset invasive bacterial and viral infections, lymphopenia, and defective T-cell, B-cell, and natural killer (NK)-cell responses. Two patients died early in childhood; after allogeneic hematopoietic stem-cell transplantation, the other three had normalization of T-cell function and clinical improvement. Results We identified biallelic mutations in the dedicator of cytokinesis 2 gene (DOCK2) in these five patients. RAC1 activation was impaired in the T cells. Chemokine-induced migration and actin polymerization were defective in the T cells, B cells, and NK cells. NK-cell degranulation was also affected. Interferon-alpha and interferon-lambda production by peripheral-blood mononuclear cells was diminished after viral infection. Moreover, in DOCK2-deficient fibroblasts, viral replication was increased and virus-induced cell death was enhanced; these conditions were normalized by treatment with interferon alfa-2b or after expression of wild-type DOCK2. Conclusions Autosomal recessive DOCK2 deficiency is a new mendelian disorder with pleiotropic defects of hematopoietic and nonhematopoietic immunity. Children with clinical features of combined immunodeficiencies, especially with early-onset, invasive infections, may have this condition. (Supported by the National Institutes of Health and others.).Source
Dobbs K, Domínguez Conde C, Zhang SY, Parolini S, Audry M, Chou J, Haapaniemi E, Keles S, Bilic I, Okada S, Massaad MJ, Rounioja S, Alwahadneh AM, Serwas NK, Capuder K, Çiftçi E, Felgentreff K, Ohsumi TK, Pedergnana V, Boisson B, Haskoloğlu Ş, Ensari A, Schuster M, Moretta A, Itan Y, Patrizi O, Rozenberg F, Lebon P, Saarela J, Knip M, Petrovski S, Goldstein DB, Parrott RE, Savas B, Schambach A, Tabellini G, Bock C, Chatila TA, Comeau AM, Geha RS, Abel L, Buckley RH, İkincioğulları A, Al-Herz W, Helminen M, Doğu F, Casanova JL, Boztuğ K, Notarangelo LD. Inherited DOCK2 Deficiency in Patients with Early-Onset Invasive Infections. N Engl J Med. 2015 Jun 18;372(25):2409-22. doi:10.1056/NEJMoa1413462. PubMed PMID: 26083206; PubMed Central PMCID: PMC4480434. Link to article on publisher's siteDOI
10.1056/NEJMoa1413462Permanent Link to this Item
http://hdl.handle.net/20.500.14038/39905PubMed ID
26083206Notes
Full author list omitted for brevity. For the full list of authors, see article.
Related Resources
Link to Article in PubMedRights
Copyright © 2015 Massachusetts Medical Society. Publisher policy allows PDF to be posted in author's institutional repository six months after article is published. See http://www.nejm.org/page/author-center/permissions.
ae974a485f413a2113503eed53cd6c53
10.1056/NEJMoa1413462